Use of anticoagulation at the time of discharge in patients with heart failure and atrial fibrillation;Uso de anticoagualción al alta hospitalaria en pacientes con insuficiencia cardíaca y fibrilación auricular

Revista Espanola de Cardiologia

Volumn 56, Issue 9, 2003, Pages 880-887

  Mosquera Pérez, Ignacio ^a   Muñiz García, Javier ^a,b   Freire Castroseiros, Evaristo ^c   García Castelo, Alberto ^d   Castro Beiras, Alfonso ^a,b,e   Fernández, Ovidio ^f   Jiménez, Manuel ^f   Masferrer Serra, Josep ^g   Eneriz Calvo, A ^g   Taboada, Hugo Torrealday ^h   Penas Cortés, José ^h   Sopeña López, Bernardo ⁱ   Platero Vázquez, M Victoria ^f   Martin E ^f   Pérez Fernández, Estrella ^f   Medraño Martínez, José Carlos ^j   Rodríguez Pascual, Carlos ^c   López Blanco, M Luz ^c   Olloz Chiva, M Teresa ^c   Casariego Rosón, Juan Raúl ^k   Alba, Medina ^k   Puente Rodero, Benito ^k   Vigil Escalera, Pedro ^k   Silva Martínez, Manuel ^f   Fernández Costa, Concepción ^f   Pedros Cuadrillero, M José ^f   Martínez Muradas, Antonio ^f   more..

^a HOSPITAL JUAN CANALEJO   (Spain)

^b UNIVERSITY OF A CORUÑA   (Spain)

^c Servicio de Cardiología   (Spain)

^d HOSPITAL XERAL CALDE   (Spain)

^e INSTITUTO ARAGONÉS DE CIENCIAS DE LA SALUD   (Spain)

^f Servicio de Medicina Interna   (Spain)

^g Hospital Comarcal de Valdeorras   (Spain)

^h HOSPITAL XERAL CÍES   (Spain)

ⁱ HOSPITAL DO MEIXOEIRO   (Spain)

^j Servicio de Geriatría   (Spain)

^k HOSPITAL MONTECELO   (Spain)

more..

Author keywords

Anticoagulants; Atrial fibrillation; Heart failure

Indexed keywords

ANGIOTENSIN 2 RECEPTOR ANTAGONIST; ANTICOAGULANT AGENT; ANTITHROMBOCYTIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; LOW MOLECULAR WEIGHT HEPARIN;

AGE DISTRIBUTION; AGED; ANAMNESIS; ANTICOAGULANT THERAPY; ANTICOAGULATION; ARTICLE; CARDIOVASCULAR PERFORMANCE; CLINICAL STUDY; CONTROLLED STUDY; DATA BASE; DRUG CHOICE; DRUG CONTRAINDICATION; DRUG INDICATION; ECHOCARDIOGRAPHY; FEMALE; HEART ATRIUM FIBRILLATION; HEART FAILURE; HEART INFARCTION; HOSPITAL ADMISSION; HOSPITAL DEPARTMENT; HOSPITAL DISCHARGE; HUMAN; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PATIENT COMPLIANCE; PRACTICE GUIDELINE; PREDICTION; PRESCRIPTION; SPAIN; VALVULAR HEART DISEASE; ADULT; CONGESTIVE HEART FAILURE; CROSS-SECTIONAL STUDY; MIDDLE AGED;

ADULT; AGED; AGED, 80 AND OVER; ANTICOAGULANTS; ATRIAL FIBRILLATION; CROSS-SECTIONAL STUDIES; FEMALE; GUIDELINE ADHERENCE; HEART FAILURE, CONGESTIVE; HUMANS; MALE; MIDDLE AGED; PATIENT DISCHARGE;

EID: 0242410147     PISSN: 03008932     EISSN: None     Source Type: Journal    
DOI: 10.1157/13051615     Document Type: Article

References (37)

1. Krahn AD, Manfreda J, Tate RB, Mathewson FAL, Cuddy ET. The natural history of atrial fibrillation: incidence, risk factors, and prognosis in the Mannitoba Follow-up Study. Am J Med 1995;98:476-84.
2. Garg R, Yusuf S, Pouler DB, editors. Congestive cardiac failure: pathophysiology and treatment. Epidemiology of Congestive Cardiac Failure, 1993; p. 9-25.
3. Jordaens L, Trouerbach J, Calle P, Tavernier R, Derycke E, Vertongen P, et al. Conversion of atrial fibrillation to sinus rhythm and rate control by digoxin in comparison to placebo. Eur Heart J 1997;18:643-8.
4. Johnstone D, Limacher M, Rousseau M, Liang CS, Ekelund L, Herman M, et al. Clinical characteristics of patients in studies of left ventricular dysfunction (SOLVD). Am J Cardiol 1992;70:894-900.
5. Swedberg K, Idanpaan Heikkila U, Remes J, and CONSENSUS Trial Study Group. Effects of enalapril on mortality in severe congestive heart failure. Results of the Coperative North Scandinavian Enalapril Survival Study (CONSENSUS). N Engl J Med 1987;316:1429-35.
6. Wolf PA, Abbott RD, Kannel WB. Atrial fibrillation as an independent risk factor for stroke: the Framingham Study. Stroke 1991;22:983-8.
7. Atrial Fibrillation Investigators. Risk factors for stroke and efficacy of antithrombotic therapy in atrial fibrillation. Analysis of pooled data from five randomized controlled trials. Arch Intern Med 1994;154:1449-57.
8. Morley J, Marinchak R, Rials SJ, Kowey P. Atrial fibrillation, anticoagulation, and stroke. Am J Cardiol 1996;77:A38-44.
9. Petersen P, Boysen G, Godtfredsen J, Andersen ED, Andersen B. Placebo-controlled, randomised trial of warfarin and aspirin for prevention of thromboembolic complications in chronic atrial fibrillation. The Copenhagen AFASAK Study. Lancet 1989;1:175-9.
10. The Boston Area Anticoagulation Trial for Atrial Fibrillation Investigators. The effect of low-dose warfarin on the risk of stroke in patients with nonrheumatic atrial fibrillation. N Engl J Med 1990;323:1505-11.
11. Stroke Prevention in Atrial Fibrillation Investigators. Stroke prevention in atrial fibrillation study. Final results. Circulation 1991;84:527-39.
12. Connolly SJ, Laupacis A, Gent M, Roberts RS, Cairns JA, Joyner C, for the CAFA Study Coinvestigators. Canadian Atrial Fibrillation Anticoagulation (CAFA) study. J Am Coll Cardiol 1991;18:349-55.
13. Ezekowitz MD, Bridgers SL, James KE, Carliner NH, Colling CL, Gornick CC, et al, for the Veterans Affairs Stroke Prevention in Nonrheumatic Atrial Fibrillation Investigators. Warfarin in the prevention of stroke associated with nonrheumatic atrial fibrillation. N Engl J Med 1992;327:1406-12.
14. EAFT (European Atrial Fibrillation Trial) Study Group. Secondary prevention in non-rheumatic atrial fibrillation after transient ischaemic attack or minor stroke. Lancet 1993;342:1255-62.
15. Stroke Prevention in Atrial Fibrillation Investigators. Warfarin versus aspirin for prevention of thromboembolism in atrial fibrillation: Stroke Prevention in Atrial Fibrillation II Study. Lancet 1994;343:687-91.
16. Stroke Prevention in Atrial Fibrillation Investigators. Adjusted-dose warfarin versus low-intensity, fixed-dose warfarin plus aspirin for high-risk patients with atrial fibrillation: Stroke Prevention in Atrial Fibrillation III randomised clinical trial. Lancet 1996;348:633-8.
17. Khand AU, Rankin AC, Kaye GC, Cleland GF. Systematic review of the management of atrial fibrillation in patients with heart failure. Eur Heart J 2000;21:614-32.
18. Almendral J, Marín E, Medina O, Peinado R, Pérez L, Ruiz R, et al. Guías de práctica clínica en arritmias cardíacas. Rev Esp Cardiol 2001;54:307-67.
19. Heras M, Fernández A, Gómez JA, Iriarte JA, Lidón RM, Pérez F, et al. Guías de actuación clínica de la Sociedad Española de Cardiología. Recomendaciones para el uso del tratamiento antitrombótico en cardiología. Rev Esp Cardiol 1999;52:801-20.
20. Fuster V, Rydén LE, Asinger RW, Cannom DS, Crijns HJ, Frye RL, et al. ACC/AHA/ESC guidelines for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines and Policy Conferences (Committee to Develop Guidelines for the Management of Patients With Atrial Fibrillation). J Am Coll Cardiol 2001;38:1231-66.
21. Brotons C, Moral I, Antón JJ, Cobos M, Cucurull E, Gállego C, et al. Tratamiento preventivo de la fibrilación auricular no reumática: de la eficacia de los ensayos clínicos a la efectividad en la práctica clínica. Atenc Primaria 1997;20:367-71.
22. Sánchez JF, García L, Chiquero M, Lozano G, Pérez S, Alonso T, et al. Tratamiento antitrombótico en la fibrilación auricular no reumática. ¿Cumplimos las recomendaciones de los ensayos clínicos? An Med Interna 1999;16:569-73.
23. Frykman V, Beerman B, Rydén L, Rosenqvist M. Management of atrial fibrillation: discrepancy between guideline recommendations and actual practice exposes patients to risk for complications. Eur Heart J 2001;22:1954-9.
24. García Castelo A, Muñiz García J, Sesma Sánchez P, Castro Beiras A. Utilización de recursos diagnósticos y terapéuticos en pacientes ingresados por insuficiencia cardíaca: influencia del servicio de ingreso (estudio INCARGAL). Rev Esp Cardiol 2003;56:49-56.
25. Nademanee K, Kosar EM. Long-term antithrombotic treatment for atrial fibrillation. Am J Cardiol 1998;82:N37-42.
26. Hylek EM, Singer DE. Risk factors for intracraneal hemorrhage in outpatients taking warfarin. Ann Intern Med 1994;120:897-902.
27. Fihn SD, Callahan CM, Martin DC, McDonell MB, Henikoff JG, White RH, for The National Consortium of Anticoagulation Clinics. The risk for and severity of bleeding complications in elderly patients treated with warfarin. Ann Intern Med 1996;124:970-9.
28. The Stroke Prevention in Atrial Fibrillation Investigators. Bleeding during antithrombotic therapy in patients with atrial fibrillation. Arch Intern Med 1996;156:409-16.
29. Gullov AL, Koefoed BG, Petersen P. Bleeding during warfarin and aspirin therapy in patients with atrial fibrillation. The AFASAK 2 Study. Arch Intern Med 1999;159:1322-8.
30. Cairns JA, Connolly SJ. Nonrheumatic atrial fibrillation: risk of stroke and role of antithrombotic therapy. Circulation 1991;84:469-81.
31. Antiplatelet Trialists' Collaboration. Collaborative overview of randomised trials for antiplatelet therapy-I: Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients. BMJ 1994;308:81-106.
32. Anticoagulants in the Secondary Prevention of Events in Coronary Thrombosis (ASPECT) Research Group. Effect of long-term oral anticoagulant treatment on mortality and cardiovascular morbidity after myocardial infarction. Lancet 1994;343:499-503.
33. The EPSIM Research Group. A controlled comparison of aspirin and oral anticoagulants in prevention of death after myocardial infarction. N Engl J Med 1982;307:701-8.
34. Julian DG, Chamberlain DA, Pocock SJ, for the AFTER Study Group. A comparison of aspirin and anticoagulation following thrombolysis for myocardial infarction (the AFTER study): a multicentre unblinded randomised clinical trial. BMJ 1996;313:1429-31.
35. Fuster V, Verstraete M. Heart disease. A textbook of cardiovascular medicine. 5th ed. Philadelphia: Saunders, 1997; p. 1828-9.
36. Anand SS, Yusuf S. Oral anticoagulant therapy in patients with coronary artery disease: a meta-analysis. JAMA 1999;282:2058-67.
37. Gull_v L, Koefoed BG, Petersen P, Pedersen TS, Andersen ED, Godtfredsen J, et al. Fixed mini-dose warfarin and aspirin alone and in combination compared with adjusted-dose warfarin for stroke prevention in atrial fibrillation. Second Copenhagen Atrial Fibrillation, Aspirin and Anticoagulation Study. Arch Intern Med 1998;158:1513-21.